Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India

被引：0
|
作者：
Saumya Srivastava
Jyotsna Mishra
Anil Kumar Gupta
Amit Singh
Prem Shankar
Sarman Singh
机构：
[1] All India Institute of Medical Sciences,Division of Clinical Microbiology and Molecular Medicine, Department of Laboratory Medicine
来源：
Parasites & Vectors | / 10卷
关键词：
Visceral leishmaniasis; Miltefosine; Drug resistance; Bihar; Jharkhand;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Laboratory diagnosis of human visceral leishmaniasis
    Sakkas, Hercules
    Gartzonika, Constantina
    Levidiotou, Stamatina
    JOURNAL OF VECTOR BORNE DISEASES, 2016, 53 (01) : 8 - 16
  • [32] A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
    Carnielli, Juliana B. T.
    Crouch, Kathryn
    Forrester, Sarah
    Silva, Vladimir Costa
    Carvalho, Silvio F. G.
    Damasceno, Jeziel D.
    Brown, Elaine
    Dickens, Nicholas J.
    Costa, Dorcas L.
    Costa, Carlos H. N.
    Dietze, Reynaldo
    Jeffares, Daniel C.
    Mottram, Jeremy C.
    EBIOMEDICINE, 2018, 36 : 83 - 91
  • [33] Effect of Itraconazole-Ezetimibe-Miltefosine Ternary Therapy in Murine Visceral Leishmaniasis
    Andrade-Neto, Valter V.
    Rebello, Karina M.
    Pereira, Thais M.
    Torres-Santos, Eduardo Caio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
  • [34] Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India
    Mahajan, Raman
    Das, Pradeep
    Isaakidis, Petros
    Sunyoto, Temmy
    Sagili, Karuna D.
    Angeles Lima, Maria
    Mitra, Gaurab
    Kumar, Deepak
    Pandey, Krishna
    Van Geertruyden, Jean-Pierre
    Boelaert, Marleen
    Burza, Sakib
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1255 - 1262
  • [35] Identification and Functional Validation of a Biomarker for the Diagnosis of Miltefosine Relapse during Visceral Leishmaniasis
    Tiwary, Puja
    Kumar, Dinesh
    Sundar, Shyam
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 98 (02) : 492 - 496
  • [36] Miltefosine in children with visceral leishmaniasis: A prospective, multicentric, cross-sectional study
    Utpal Kant Singh
    Rajniti Prasad
    O. P. Mishra
    B. P. Jayswal
    The Indian Journal of Pediatrics, 2006, 73 (12) : 1077 - 1080
  • [37] Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
    Nogueira, Fabio dos Santos
    Avino, Valdir Carlos
    Galvis-Ovallos, Fredy
    Pereira-Chioccola, Vera Lucia
    Batistella Moreira, Marcio Antonio
    Peres Lopes Romariz, Ana Paula
    Molla, Leticia M.
    Menz, Ingrid
    PARASITES & VECTORS, 2019, 12
  • [38] Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis
    Nishi Shakya
    Shraddha A. Sane
    Wahajul Haq
    Suman Gupta
    Parasitology Research, 2012, 111 : 563 - 570
  • [39] Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: Role of TLR4 and TLR9
    Mukherjee, Asok Kumar
    Gupta, Gaurav
    Adhikari, Anupam
    Majumder, Saikat
    Mahapatra, Santanu Kar
    Majumdar, Suchandra Bhattacharyya
    Majumdar, Subrata
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 12 (04) : 565 - 572
  • [40] Visceral leishmaniasis in Saudi Arabia: From hundreds of cases to zero
    Abuzaid, Abuzaid A.
    Aldahan, Mohamed A.
    Al Helal, Mohammed A.
    Assiri, Abdullah M.
    Alzahrani, Mohamed H.
    ACTA TROPICA, 2020, 212
12345